0001410939-22-000082.txt : 20220705 0001410939-22-000082.hdr.sgml : 20220705 20220705183025 ACCESSION NUMBER: 0001410939-22-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220705 DATE AS OF CHANGE: 20220705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibney Anthony S CENTRAL INDEX KEY: 0001750132 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 221066857 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_165706020499268.xml FORM 4 X0306 4 2022-06-30 0 0001410939 IVERIC bio, Inc. ISEE 0001750132 Gibney Anthony S C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 EVP, Chief Business Officer Common Stock 2022-06-30 4 M 0 18750 0 A 18750 D Common Stock 2022-07-05 4 S 0 7791 9.41 D 10959 D Restricted Stock Units 2022-06-30 4 M 0 18750 0 D Common Stock 18750.0 56250 D Restricted stock units converted into common stock on a one-for-one basis upon vesting upon the achievement of certain performance criteria, pursuant to the applicable Restricted Stock Unit Agreement. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on June 30, 2022. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $9.37 to $9.47 on July 5, 2022 on behalf of the Reporting Person to satisfy the payment of withholding tax liability of the Reporting Person. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan, the award of restricted stock units will vest based on the achievement of certain performance milestones. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Anthony Gibney 2022-07-05